CL
MRNA icon

Choreo LLC’s Moderna MRNA Stock Holding History

Choreo LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,082
Closed -$207K – 1755
2026
Q1 		$207K Buy
+4,082
New +$190K ﹤0.01% 1462
2024
Q4 		– Sell
-6,585
Closed -$421K – 1692
2024
Q3 		$421K Sell
6,585
-319
-5% -$29.3K 0.01% 999
2024
Q2 		$802K Buy
+6,904
New +$874K 0.01% 602
2021
Q4 		– Sell
-660
Closed -$254K – 235
2021
Q3 		$254K Buy
+660
New +$243K 0.01% 187

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Choreo LLC's MRNA Position: Q2 2026 in Review

Choreo LLC sold out of Moderna (MRNA) in Q2 2026, closing a stake of 4,082 shares — an estimated $207K sold.

Choreo LLC first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $802K in Q2 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Choreo LLC reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Choreo LLC sold 4,082 Moderna shares in Q2 2026, an estimated $207K.
  • Choreo LLC first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
  • Choreo LLC's Moderna position peaked at $802K in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.